Overview

Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spray and Dymista Nasal Spray

Status:
Completed

Trial end date:
2023-07-05

Target enrollment:

Participant gender:

Summary

Single dose (four sprays) bioequivalence study of Azelastine Hydrochloride/ Fluticasone Propionate 137 microgram/50 microgram Nasal Spray and 'DYMISTA' (Azelastine Hydrochloride/Fluticasone Propionate) Nasal Spray 137 microgram/50 microgram in healthy adult human subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Humanis Saglık Anonim Sirketi

Treatments:

Azelastine
Fluticasone
Xhance